Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,756 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CHD7 and Runx1 interaction provides a braking mechanism for hematopoietic differentiation.
Hsu J, Huang HT, Lee CT, Choudhuri A, Wilson NK, Abraham BJ, Moignard V, Kucinski I, Yu S, Hyde RK, Tober J, Cai X, Li Y, Guo Y, Yang S, Superdock M, Trompouki E, Calero-Nieto FJ, Ghamari A, Jiang J, Gao P, Gao L, Nguyen V, Robertson AL, Durand EM, Kathrein KL, Aifantis I, Gerber SA, Tong W, Tan K, Cantor AB, Zhou Y, Liu PP, Young RA, Göttgens B, Speck NA, Zon LI. Hsu J, et al. Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23626-23635. doi: 10.1073/pnas.2003228117. Epub 2020 Sep 3. Proc Natl Acad Sci U S A. 2020. PMID: 32883883 Free PMC article.
Chd7 deficiency delays leukemogenesis in mice induced by Cbfb-MYH11.
Zhen T, Kwon EM, Zhao L, Hsu J, Hyde RK, Lu Y, Alemu L, Speck NA, Liu PP. Zhen T, et al. Among authors: hsu j. Blood. 2017 Nov 30;130(22):2431-2442. doi: 10.1182/blood-2017-04-780106. Epub 2017 Oct 10. Blood. 2017. PMID: 29018080 Free PMC article.
Specific Class I HLA Supertypes but Not HLA Zygosity or Expression Are Associated with Outcomes following HLA-Matched Allogeneic Hematopoietic Cell Transplant: HLA Supertypes Impact Allogeneic HCT Outcomes.
Camacho-Bydume C, Wang T, Sees JA, Fernandez-Viña M, Abid MB, Askar M, Beitinjaneh A, Brown V, Castillo P, Chhabra S, Gadalla SM, Hsu JM, Kamoun M, Lazaryan A, Nishihori T, Page K, Schetelig J, Fleischhauer K, Marsh SGE, Paczesny S, Spellman SR, Lee SJ, Hsu KC. Camacho-Bydume C, et al. Among authors: hsu jm, hsu kc. Transplant Cell Ther. 2021 Feb;27(2):142.e1-142.e11. doi: 10.1016/j.bbmt.2020.10.010. Epub 2020 Oct 11. Transplant Cell Ther. 2021. PMID: 33053450 Free PMC article.
Cord blood transplants supported by unrelated donor CD34+ progenitor cells.
Gomez-Arteaga A, Orfali N, Guarneri D, Cushing MM, Gergis U, Hsu J, Hsu YS, Mayer SA, Phillips AA, Chase SA, Mokhtar AE, Shore TB, Van Besien K. Gomez-Arteaga A, et al. Among authors: hsu ys, hsu j. Bone Marrow Transplant. 2020 Dec;55(12):2298-2307. doi: 10.1038/s41409-020-0959-5. Epub 2020 Jun 9. Bone Marrow Transplant. 2020. PMID: 32518291
HIV-1 remission and possible cure in a woman after haplo-cord blood transplant.
Hsu J, Van Besien K, Glesby MJ, Pahwa S, Coletti A, Warshaw MG, Petz L, Moore TB, Chen YH, Pallikkuth S, Dhummakupt A, Cortado R, Golner A, Bone F, Baldo M, Riches M, Mellors JW, Tobin NH, Browning R, Persaud D, Bryson Y; International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) P1107 Team. Hsu J, et al. Cell. 2023 Mar 16;186(6):1115-1126.e8. doi: 10.1016/j.cell.2023.02.030. Cell. 2023. PMID: 36931242 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 36163765
Impact of alemtuzumab dosing and low-dose total body irradiation on cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation.
Brown M, Abasov R, Salerno D, Shore TB, Gergis U, Mayer S, Phillips A, Hsu J, Kodiyanplakkal RPL, Pasciolla M, van Besien K. Brown M, et al. Among authors: hsu j. Leuk Lymphoma. 2020 Dec;61(12):3024-3026. doi: 10.1080/10428194.2020.1791855. Epub 2020 Jul 11. Leuk Lymphoma. 2020. PMID: 32654572 No abstract available.
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk.
Van Besien K, Bachier-Rodriguez L, Satlin M, Brown MA, Gergis U, Guarneri D, Hsu J, Phillips AA, Mayer SA, Singh AD, Soave R, Rossi A, Small CB, Walsh TJ, Rennert H, Shore TB. Van Besien K, et al. Among authors: hsu j. Leuk Lymphoma. 2019 Jul;60(7):1693-1696. doi: 10.1080/10428194.2018.1543877. Epub 2019 Feb 10. Leuk Lymphoma. 2019. PMID: 30741059
Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes.
Gergis U, Frenet EM, Shore T, Mayer S, Phillips A, Hsu JM, Roboz G, Ritchie E, Scandura J, Lee S, Desai P, Samuel M, Ball J, Blanco A, Romeo C, Albano MS, Dobrila L, Scaradavou A, van Besien K. Gergis U, et al. Among authors: hsu jm. Biol Blood Marrow Transplant. 2019 Mar;25(3):466-473. doi: 10.1016/j.bbmt.2018.11.002. Epub 2018 Nov 9. Biol Blood Marrow Transplant. 2019. PMID: 30414955 Free article.
5,756 results